Parkin mutations in humans produce parkinsonism whose pathogenesis is related to impaired protein degradation, increased free radicals, and abnormal neurotransmitter release. The role of glia in parkin deficiency is little known. We cultured midbrain glia from wild-type (WT) and parkin knock-out (PK-KO) mice. After 18 -20 d in vitro, PK-KO glial cultures had less astrocytes, more microglia, reduced proliferation, and increased proapoptotic protein expression.
Introduction
Parkinson's disease (PD) is a multifactorial neurodegenerative disease (Litvan et al., 2007a,b) of genetic origin in 25% of the cases. Park-2, one of the genes responsible for autosomal recessive PD (AR-PD) codes for parkin, an ubiquitin E3 ligase protein (Kitada et al., 1998; Moore, 2006) , whose suppression induces neuronal death related to abnormal processing of degraded proteins. Other pathogenic mechanisms may play additional roles in parkin-related AR-PD and may help to explain the selective lesion of the nigrostriatal pathway that occurs in these patients.
Astrocytes, the most abundant glial cells, support the differentiation, survival, pharmacological properties, and resistance to injury of dopamine neurons (Mena et al., 2002; Takuma et al., 2004) . The role of glia is mediated by the secretion of chemical substances into the media (Mena et al., 1997a (Mena et al., , 2002 de Bernardo et al., 2003) . Dysfunctional astrocytes enhance neuronal degeneration by a diminished secretion of trophic factors (Riederer et al., 1989; Engele et al., 1991 Engele et al., , 1996 Damier et al., 1993; Makar et al., 1994; Muller et al., 1995; Mena et al., 1997a Mena et al., , 1998b Mena et al., , 2002 Kinor et al., 2001) , the release of cytokines, and the increased production of reactive oxidative molecules (Hirsch et al., 1999; Liberatore et al., 1999; Hirsch and Hunot, 2000; Vila et al., 2001; Wu et al., 2002; Canals et al., 2003b; de Bernardo et al., 2004) .
Parkin enhances the survival of the dopamine neurons (Kitada et al., 1998; Abbas et al., 1999; Lucking et al., 2000) . A putative role of parkin in glial function could explain a selectivity of parkin dysfunction in nigrostriatal dopamine neurons because these cells have the smallest glial/neuron ratios of the brain (Damier et al., 1993) , and, therefore, the consequences of glial dysfunction in them could be more critical than in other brain regions. Parkin dysfunction impairs astrocytic function and contributes to the pathogenesis of parkin-linked AR-PD (Ledesma et al., 2002) . Furthermore, a reduction in parkin levels renders the rat glial-like cell line RG-6 more susceptible to dopamine (DA)-and H 2 O 2 -induced cell death (MacCormac et al., 2004) .
Parkin knock-out (PK-KO) mice are used to investigate the role of parkin (Goldberg et al., 2003; Itier et al., 2003; Von Coelln et al., 2004; Perez and Palmiter, 2005) . These mice present abnormal release and metabolism of dopamine and increased susceptibility to rotenone in early adulthood and severe dopamine cell loss while aging (Itier et al., 2003; Casarejos et al., 2005 Casarejos et al., , 2006  For glial cultures, the ventral mesencephalon was removed from embryonic tissue (day 13 of gestation), diced in small fragments, and incubated in trypsin-EDTA (0.5% in HBSS) at 37°C for 15 min. Trypsinization was stopped by adding culture medium, and the tissue was gently centrifuged. The supernatant was discarded, and the pellet was resuspended in 1 ml of culture medium. Single-cell dissociation was achieved by mechanical disruption. Dissociated cells were plated in DMEM with 15% (v/v) heat-inactivated fetal bovine serum, 4 mM L-glutamine, 1 mM pyruvate, and 100 U/ml penicillin-streptomycin (growth medium; DMEM-FCS) (de Bernardo et al., 2003) at a density of 3 ϫ 10 6 cells per 80 cm 2 cell culture flask. Culture medium was refreshed after 6 -7 d and every 7 d thereafter. After 18 d in culture, positive staining with anti-GFAP antibody identified the astrocytes in these cultures and contained at least 80 -90% of total cells.
To obtain the glia-conditioned medium (GCM), DMEM-FCS medium was discarded, and the cells were washed out three times with Leibovitz's L-15 medium and subsequently cultured in a chemically serum-free defined medium (EF12) (Mena et al., 1993; Pardo et al., 1997) . After 24 h of culture under such conditions, the medium was collected and stored frozen. This medium was considered GCM. EF12 consisted of a 1:1 (v/v) EMEM and nutrient mixture of Ham's F-12, supplemented with D-glucose (6 mg/ml), insulin (25 mg/ml), transferrin (100 mg/ml), putrescine (60 mM), progesterone (20 nM), and sodium selenite (30 nM).
Neuronal-enriched mesencephalic primary cultures were obtained and prepared as described previously . The ventral mesencephalon was removed from embryonic tissue (day 13 of gestation) and incubated with 0.36 mg/ml papain in PBS/D-glucose (6 mg/ ml)/1% BSA buffer for 15 min at 37°C and mechanically dissociated in the presence of 10 mg/ml DNase-I. The cells were seeded in B27/Neurobasal TM medium with 15% (v/v) heat-inactivated fetal calf serum (B27/ NBL-FCS) supplemented with glutamine (4 mM) and penicillin-streptomycin (100 U/ml) at a density of 2.5 ϫ 10 5 cells/cm 2 in multiwells or 2 ϫ 10 5 cells/cm 2 in glass cover slides precoated with poly-D-lysine (4.5 g/cm 2 ) in 0.1 M borate buffer, pH 8.4, and laminin (3 g/ml). The cultures were kept in a humidified chamber at 37°C in a 5% CO 2 atmosphere for 7-8 d in vitro. Twenty-four hours after plating, the cells were changed to serum-free medium (B27/NBL).
Treatment of the cells. After 15-20 d in vitro (DIV) in the growth medium (DMEM-FCS), glial cultures had reached confluency; at this time, the cells were mildly trypsinized and reseeded for the different experiments at a density of 1.3 ϫ 10 4 cells/cm 2 in 24-, 12-, or 6-well plate cultures and maintained in growth medium for 5-6 additional days for cell viability studies, detoxification, enzymatic activities, and protein and mRNA expression studies, respectively. For BrdU proliferation studies, TUNEL and propidium iodide assays, and phenotype characterization, the cells were seeded at 20,000 cells/cover slide and used 3 and 6 d after seeding, respectively. For [ 3 H]DA uptake in glial cultures, we used 30 -45 DIV glial cultures, after testing that only glial cells were present, at a density of 1.3 ϫ 10 4 cells/cm 2 in 24-well plate cultures and maintained in growth medium for 6 additional days.
To study the effects of different oxidative stress insults, after 5 d of reseeding in 24-well plates, the growth medium was changed to serumfree defined medium (EF12) and incubated during 24, 52, or 72 h alone or in presence of MPP ϩ (30 M). In another set of experiments, 6 -7 DIV after seeding, the cells were treated with H 2 O 2 (50, 100, or 200 M) for different times, in EMEM plus D-glucose (6 mg/ml), the most appropriated medium for H 2 O 2 studies.
To assess the relative contributions of glutathione (GSH) and catalase to H 2 O 2 toxicity, glial cultures were preincubated either for 24 h with the GSH synthesis inhibitor BSO (40 M) or 2 h with the catalase activity inhibitor 3AT (10 mM) before the addition of H 2 O 2 (100 or 200 M) for 3 h. For BSO plus 3AT conditions, cells were incubated for 24 h with BSO and for the last 2 h with 3AT.
The roles of the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3 kinase (PI3K) signaling pathways in the H 2 O 2 effects in WT and PK-KO glial cultures were investigated using the mitogen ERK-1/2 inhibitor PD98059 (15 M) and the specific PI3K inhibitor LY-294002 (25 M), 30 min before the H 2 O 2 treatment (200 M for 3 h). The iron contribution to the cytotoxicity induced by hydrogen peroxide treatment was studied by iron supplementation, with FeSO 4 (50 M), and iron chelating, with DFO. FeSO 4 (50 M) was added to the cells at the time of H 2 O 2 (100 M) treatment, and DFO was added in a final concentration of 2 or 4 mM, 2 h before the application of the peroxide.
In longitudinal studies, the effects of aging in WT and PK-KO glial cultures were performed maintaining the glial cultures during different periods of time, from 20 DIV to 9 months, changing the growth medium (DMEM-FCS) every week.
The effect of WT and PK-KO GCM on cell survival and DA expression was investigated in 6 DIV neuronal-enriched mesencephalic primary cultures treated during 24 h with defined medium or WT and PK-KO glia-conditioned medium. The number of TH ϩ , microglial, and apoptotic cells present in the neuronal cultures was counted after 24 h of incubation with GCM or defined medium.
Immunocytochemistry. After 7 DIV, midbrain WT and PK-KO cultures were used for phenotype studies. Astrocytes were characterized by immunostaining with a rabbit anti-GFAP antibody (1:500). Microglial cells were identified with isolectin B4 peroxidase-labeled (12.5 g/ ml) (Streit and Kreutzberg, 1987; Ashwell, 1991) or rat anti-CD11b antibody (1:50). In neuronalenriched midbrain cultures, DA neurons were characterized by immunostaining with a mouse anti-TH antibody (1:500).
The cells were fixed with 4% paraformaldehyde, washed in 0.1 M PBS, pH 7.4, permeabilized with ethanol/acetic acid (19:1), and incubated at 4°C for 24 h with primary antibodies diluted in PBS containing 10% fetal bovine serum. CD11b antibody, diluted in TBS/0.1% Triton X-100, was added to fixed cells without permeabilization. Fluorescein-and Alexa Fluor-conjugated secondary antibodies were used to visualize positive cells under fluorescent microscopy. For microglial cells identification with isolectin B4 peroxidase-labeled, cultures were fixed with 4% paraformaldehyde-1% glutaraldehyde and incubated overnight at 4°C with isolectin B4 peroxidase-labeled diluted in TBS/0.1% Triton X-100; the positive cells were developed with a DAB system (LSAB2 system; DakoCytomation) and visualized under optical microscopy. Total nuclei were stained with bis-benzimide.
The number of immunoreactive cells was counted in one-seventh of the total area of the cover slides, and the nuclei were stained with bisbenzimide added in the anti-fading solution and counted in 10 predefined fields that represent 1 ⁄14 of the cover slide area. The cells were counted in predefined parallel strips using a counting reticule inserted into the ocular.
3 H-Dopamine uptake. ascorbic acid, at 37°C for 20 min. Nonspecific uptake/binding was calculated in the presence of 10 Ϫ5 M mazindol for neuronal cultures or 1-10 M GBR 12935 (dopamine transporter inhibitor) for glial cultures and represented Յ5% (Mena et al., 1993; Pardo et al., 1997) .
BrdU incorporation. Three days after reseeding in the growth medium, WT and PK-KO glial cultures were incubated with 5-bromo-3-deoxyuridine (5 ϫ 10 Ϫ5 M). Twenty-four hours later, cells were fixed with 4% paraformaldehyde, permeabilized with ethanol/acetic acid solution Measurement of the cell viability. Mitochondrial activity was analyzed with the MTT assay in WT and PK-KO glial cultures. The MTT assay determines the ability of cells to metabolize MTT. At the end of the cell treatment period, 300 l of culture medium was removed from total 500 l of each well, and 20 l of MTT solution (5 mg/ml) was added and incubated for 2 h. At this time, 200 l of solubilization solution (10% SDS in 0.01 M HCl) was then added to the wells, and, after 24 h of incubation at 37°C, 100 l were transferred into a 96-well microtiter plate, and the absorption value at 540 nm was measured in an automatic microtiter reader (Spectra Fluor; Tecan, Männedorf, Switzerland).
Apoptosis was measured by light microscopy features, DNA staining, and the TUNEL assay. Cells growing on cover slides were fixed in 4% paraformaldehyde, and the nuclei were stained with bis-benzimide (Hoechst 33342) added to the anti-fading solution, 3 ϫ 10 Ϫ6 M final concentration (Pardo et al., 1997) , and counted in 1 ⁄14 of the cover slide area; apoptotic cells were identified by chromatin condensation.
TUNEL detection system for apoptosis measures the fragmented DNA of cells by incorporating fluorescein-12-dUTP* at the 3Ј-OH ends of the DNA by using the enzyme terminal deoxynucleotidyl transferase (TdT) (Gavrieli et al., 1992) . For this assay, the cells were fixed in 4% paraformaldehyde and permeabilized with 0.2% Triton X-100. The fluorescein-12-dUTP-labeled DNA of apoptotic cells was visualized by fluorescence microscopy. The number of TUNEL ϩ cells was counted in 1 ⁄14 of the cover slide area. Cells were counted in predefined parallel strips by using a counting reticule in the microscope ocular. Cells incubated with buffer in the absence of TdT enzyme were used as negative controls.
For necrotic cell death, lactate dehydrogenase activity was measured in the culture medium by using a cytotoxicity detection kit and PI dye exclusion assay was performed. Propidium iodide is membrane impermeable and excluded from viable cells. The number of red fluorescence PI ϩ cells was counted in one-seventh of the total area of the cover slides, in predefined parallel strips using a counting reticule inserted into the microscope ocular.
Measurement of GSH. Total glutathione levels in WT and PK-KO glial cultures were measured by the method of Tietze (1969) . Briefly, cells from fetal midbrain cultures were washed with PBS, lysed in 100 l of 0.4 N perchloric acid (PCA) for 30 min at 4°C, and centrifuged, and the supernatants were neutralized with four volumes of 0.1 M NaH 2 PO 4 and 5 mM EDTA, pH 7.5. Glutathione content was measured in a P96 automatic reader by the addition of 5,5Ј dithio-bis-2-nitrobenzoic acid (0.6 mM), NADPH (0.2 mM), and glutathione reductase (1 U), and the reaction was monitored at 412 nm for 6 min. Oxidized glutathione (GSSG) was measured in the cells by the method of Griffith (1980) . Briefly, after PCA extraction and pH neutralization, reduced glutathione (GSH) was derivatized with 2-vinylpyridine at room temperature for 1 h, and the reaction performed as above. GSH was obtained by subtracting GSSG levels from total glutathione levels.
To analyzed the GSH levels in GCM, we added 10 l of 1N PCA to 50 l of GCM, and, after centrifugation, the supernatant was used as above.
Glutathione peroxidase, glutathione S-transferase, and catalase enzyme activity assay. In WT and PK-KO glial cultures after 7 DIV, the cells were washed with PBS, harvested by centrifugation at 1000 ϫ g for 5 min, pooled in 110 l of 50 mM potassium phosphate, pH 7.2, 1 mM EDTA, and sonicated. The homogenate was centrifuged at 10,000 ϫ g for 15 min at 4°C, and the supernatant was used for glutathione peroxidase (GPx), catalase activity, and protein determination. GPx activity was measured according to the method of Flohe and Gunzler (1984) . Briefly, 110 l of 50 mM potassium phosphate, pH 7.2, 1 mM EDTA, 25 l of 10 mM GSH, and 25 l of GSH reductase (0.6 U/l) were added over 40 l of the cell homogenates. This reaction mixture was incubated for 5 min at 37°C, after which 25 l of 1.5 mM NADPH was added. The change in absorbance was followed at 340 nm for 5 min at room temperature to quantify the hydroperoxide independent oxidation of NADPH. Twenty-five microliters of 12 mM tert-butyl hydroperoxide were then added, and the rate of NADPH oxidation was followed at 340 nm for 5 min. One unit of GPx activity is the amount of enzyme necessary to oxidize 1 mol of NADPH per minute.
For catalase activity measurement, we used 10 l of the cell homogenates obtained as above. The assay is based on the reaction of the enzyme with methanol in the presence of an optimal concentration (4.2 mM) of hydrogen peroxide. The formaldehyde produced was measured spectrophotometrically with 4-amino-3-hydrazino-5-mercapto-1,2,4-triazole (Purpald) as a chromogen at 540 nm (Johansson and Borg, 1988) . One unit of catalase is the amount of enzyme necessary to produce 1 mol of formaldehyde per minute. Glutathione transferase activity in WT and PK-KO glial cultures was determined by the method of Habig et al. (1974) , using CDNB. After 7 DIV, the cells were washed with PBS, harvested by centrifugation at 1000 ϫ g for 5 min, pooled in 110 l of 0.1 M potassium phosphate, pH 7.0, and 1 mM EDTA, and sonicated. The homogenate was centrifuged at 10,000 ϫ g for 15 min at 4°C, and the supernatant was used in the enzyme assay. The assay mixture consisted of 140 l of 0.1 M potassium phosphate, pH 6.5, 20 l of 1 mM CDNB, 20 l of 1 mM GSH, and 20 l of supernatant. The formation of the adduct of CDNB (S-2,4-dinitrophenyl glutathione) was monitored by measuring the rate of increase in absorbance at 340 nm at 25°C for 5 min.
Determination of H 2 O 2 concentration. The concentration of H 2 O 2 in midbrain glial cultures was estimated with a colorimetric assay, in the most appropriate experimental culture media (EMEM plus glucose) for the H 2 O 2 stability. After the experimental treatments, the media was centrifuged at 10,000 ϫ g for 2 min, and 100 l of the supernatants were added to 50 l of 3,3Ј-dimethoxybenzidine (2 mM) and 50 l of horseradish peroxidase (240 IU/ml). 3,3Ј-Dimethoxybenzidine, which is colorless in its reduced form, is oxidized in the presence of H 2 O 2 and peroxidase into a red-colored product. Optical density was estimated at 490 nm. The concentration of H 2 O 2 in the culture media was determined using standard solutions.
Western blot analysis. Glial midbrain cultures were homogenized with a sonicator in lysis buffer containing 20 mM Tris-HCl, 10 mM potassium acetate, 1 mM dithiothreitol, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine, leupeptin, aprotinin, and pepstatin at 5 g/ml each, and 0.25% NP-40, pH 7.4, and then centrifuged at 12,000 ϫ g for 30 min at 4°C. For p-ERK and total ERK detection, 10 mM sodium fluoride, 2 mM sodium molibdate, 10 mM ␤-glicerophosphate, and 0.2 mM orthovanadate were added to the lysis buffer. The supernatant was used for protein determination by the BCA protein assay kit and for electrophoretical separation. Samples (20 -40 g of protein) were added to SDS sample loading buffer, electrophoresed in 10% SDSpolyacrylamide gels, and then electroblotted to 0.45 m nitrocellulose membranes. For immunolabeling, the blots were blocked with TTBS [20 mM Tris-HCl, pH 7.6, 137 mM NaCl plus 0.1% (v/v) Tween-20 and 5% dry skimmed milk] for 1 h at room temperature. After blocking nonspecific binding, the membranes were incubated with different specific primary antibodies in blocking solution overnight at 4°C. The blots were developed by chemiluminescence detection using a commercial kit (GE Healthcare, Little Chalfont, UK) and quantified by computer-assisted video densitometry.
We used a rabbit polyclonal anti-parkin antibody diluted 1:500 to confirm the genotype of the WT and PK-KO glial cultures. For astroglial and microglial, mouse monoclonal anti-GFAP antibody diluted 1:5000 and mouse monoclonal anti-OX6 (1:500), respectively, were used. Other antibodies and dilutions used in the study were as follows: mouse monoclonal anti-HSP-70 (1:500) and rabbit polyclonal antiBclx L/S antibody diluted 1:500; anti-phospho-ERK-1/2 and rabbit anti-ERK-1/2 diluted 1:5000 and 1:10,000, respectively. Mouse monoclonal anti-␤-actin antibody diluted 1:5000 was used as a control of charge after inactivation of nitrocellulose membrane with sodium azide. Goat anti-mouse HRP and anti-rabbit HRP secondary antibodies were diluted 1:1000. ␤-Actin secondary antibody was an anti-mouse phosphatase alkaline conjugate diluted 1:300. RNA isolation and cDNA synthesis. The glial cultures from WT and PK-KO mice were homogenized in 1 ml of TRI Reagent (Invitrogen) per 10 cm 2 of dish area and centrifuged at 12,000 ϫ g for 10 min at 4°C. Chloroform was added to the supernatant, mixed well, and incubated at room temperature for 5 min. The mix was centrifuged at 12,000 ϫ g for 10 min at 4°C, and the aqueous phase was mixed with isopropanol, vortexed for 5-10 s, and incubated at room temperature for 10 min. After centrifugation at 12,000 ϫ g for 8 min at 4°C, the supernatant was discarded, and 1 ml of 75% ethanol was added. To remove the ethanol, it was centrifuged at 7,500 ϫ g for 5 min, and the RNA pellet was briefly air dried. Total RNA was dissolved in DEPC water, and the integrity was verified by electrophoresis.
After the quantification in NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE), 2 g of total RNA, 1 l of 100 M oligo-dT, and water DEPC until 16 l were incubated at 70°C for 5 min in the 2720 Thermal Cycler (Applied Biosystems, Warrington, UK). After cooling on ice, 9 l of the reaction mixture [5 l of 5ϫ buffer, 2 l of 10 mM dNTPs, 0.5 l of RNasin (Roche, Indianapolis, IN), and 1.5 l of avian myeloblastosis virus reverse transcriptase (Roche)] were added to each sample. The reverse transcription (RT) cycles were 70°C 5 min, 42°C 1 h, and 90°C 3 min in the 2720 Thermal Cycler.
Real-time quantitative PCR. Expression levels of ␥-glutamylcysteine synthetase (␥-GCS) mRNA were examined by iQ SybrGreen qPCR (Bio-Rad, Hercules, CA), on reverse-transcribed total RNA isolated from the glial cultures. Amplification reactions were performed in triplicate with 40 ng of cDNA sample, 1.5 M gene specific primers, and 1ϫ iQ SybrGreen Supermix (Bio-Rad), in 25 l final volume. The primers were designed with PrimerBank, and the sequences 5Ј to 3Ј were as follows: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) forward, TGACCACAGTCCATGCCATC; GAPDH reverse, GACGGACACATTGGGGGTAG; ␥-GCS forward, GGGGTGACGAG-GTGGAGTA; and ␥-GCS reverse, GTTGGGGTTTGTCCTCTCCC. RTquantitative PCR (qPCR) was performed on an iCycler detector (BioRad) with the following thermal profile conditions: 95°C for 10 min, 45 cycles of 95°C for 30 s, and 59°C for 1 min. To differentiate specific amplicons from nonspecific products using SybrGreen, a DNA dissociation curve was generated after each reaction with the iCycler sequence detection system. ␥-GCS mRNA was quantified relative to GAPDH mRNA using the comparative threshold cycle number (Ct) method. The Ct difference (␦C t ϭ C t ␥-GCS ϫ C t GAPDH) was taken as a relative quantity of the transcript, and the ␦C t from each PK-KO and WT glial cell well was compared with the mean of the WT ␦C t and expressed as 2 ⌬⌬Ct . The amplification efficiency was checked and found to be similar for both genes.
Statistical analysis. The results were statistically evaluated for significance with one-way ANOVA followed by Newman-Keuls multiple comparison test. The interactions between the genotype and the treatment or between genotype and the age of the cells were analyzed by two-way ANOVA. Differences were considered statistically significant when p Ͻ 0.05. Analysis of data were performed using the GraphPad Software (San Diego, CA) Prism 4 software.
Results
Characterization of fetal mesencephalic glial cultures from parkin null mice WT and PK-KO glial mesencephalic cultures used in these studies were kept in culture for different periods of time from 15 d up to 9 months in DMEM-FCS. After 15-20 d in culture, the glial cells reached confluence. The cultures from both WT and PK-KO mice had the same morphology. The cellular characterization of glial cultures (15-20 DIV) by immunocytochemistry showed that they were predominantly composed by type 2 astrocytes (GFAP ϩ ) and by a small percentage of microglial cells (Cd11b ϩ ) (Fig. 1 A) . PK-KO glial cultures had a reduced proportion of astrocytes, as measured by the levels of GFAP protein analyzed by Western blot (Fig. 1 B) , which were ϳ20% lower in PK-KO with respect to WT glial cultures, and higher percentage of microglial cells, visualized by CD11b ϩ or isolectin B4 staining (Fig. 1C ) (3.89% CD11b ϩ cells in WT vs 5.86% in PK-KO cultures). PK-KO glial cultures (15-20 DIV) present a lower cell proliferation ratio than those of WT, as shown by the BrdU ϩ incorporation (Fig. 1 D, E) .
The expression of Bclx L/S proteins, considered an index of apoptotic activity because Bclx L is a protein of survival and Bclx S is a proapoptotic protein, shows a significant increase of proapoptotic activity in PK-KO glial cultures (Fig. 1 F) . We measured the intracellular GSH level and detoxification enzyme activities. As shown in Figure 2 A, the level of intracellular GSH was 39% higher in glial PK-KO cultures than in WT. Furthermore, PK-KO young glial cultures have higher ␥-glutamylcysteine synthetase, the rate-limiting GSH synthesis enzyme, mRNA levels than their age-matched WT (Fig. 2 B) . The specific activity of GPx was reduced in PK-KO cultures with respect to that of WT (Fig. 2C) and that of catalase was unchanged. To investigate the redox state in the parkin null glial cultures, we also measured glutathione S-transferase (GST) activity in WT and PK-KO glial cultures. GST activity was increased in PK-KO cultures with respect to WT (Fig. 2 D) .
Differential effects of oxidative stress in WT and PK-KO glial cultures
To determine whether the loss of parkin protein has an effect on the response of glial cultures to oxidative stress, we investigated the effects of serum deprivation and exposure to MPP ϩ in serum-free medium in WT and PK-KO cultures. As shown in Figure 3 , the incubation of glial cultures with a chemically defined serum-free medium [EF12 (DM)] (Mena et al., 1993; Pardo et al., 1997) for different periods of time led to an elevation of intracellular GSH levels, greater in WT than in PK-KO cultures, 24 h after withdrawal of serum (Fig. 3A) . In addition, there was a greater H 2 O 2 production in PK-KO cultures (Fig. 3H ) . Furthermore, after 52 and 72 h of incubation in serum-free defined medium, the number of necrotic (propidium iodide ϩ ) (Fig. 3B ) and apoptotic (TUNEL ϩ ) (Fig.  3C ) cells and the levels of LDH released to the medium (Fig.  3D) were increased in both types of cultures, significantly higher in PK-KO than in WT (Fig. 3B-D) . In addition, the incubation of glial cells in EF12 for 24 h increased the intensity and area of GFAP ϩ cells, more in PK-KO than WT glial cultures (Fig. 3 E, F ) .
Treatment with MPP ϩ (30 M), a compound that selectively inhibits complex I of the mitochondrial respiratory chain (Nicklas et al., 1985; , for 24 h, in defined medium, led to a greater release of H 2 O 2 to the medium in PK-KO than WT glial cultures (Fig. 3H ) and to greater elevation of LDH in PK-KO than in WT cultures (Fig.  3G) .
Parkin null glial cultures are more resistant to hydrogen peroxide-induced toxicity
We investigated whether WT and PK-KO glial cultures respond in a different manner to a direct mediator of oxidative stress as H 2 O 2 . To evaluate the concentrationdependent effect of H 2 O 2 on cell viability, 20 -30 DIV cells maintained in growth medium (DMEM-FCS) were reseeded in 24-well plates, and, after 6 -7 DIV, the medium was replaced by EMEM plus D-glucose (6 mg/ml), the most appropriate medium for the H 2 O 2 stability. The cultures were then treated with H 2 O 2 , from 50 to 200 M, for 2-3 h. As shown in Figure 4 , the exposure to H 2 O 2 produced a dosedependent reduction of cell viability in WT and PK-KO glial cultures. PK-KO glial cultures were more resistant than WT to the effects of 100 M H 2 O 2 , but the differences in susceptibility disappeared at concentrations of 200 M H 2 O 2 . Viability curves obtained by MTT assay are shown in Figure 4 A and LDH levels in the medium in Figure 4 B.
The intracellular levels of GSH after incubation with 200 M H 2 O 2 for 10, 30, and 60 min are shown in Figure 4C . The GSH content decreases with the length of exposure to H 2 O 2 in WT and PK-KO glial cells; the GSH levels were always higher in PK-KO than in the WT cultures.
To elucidate the relative contribution of the GSH system and of the catalase to H 2 O 2 -induced cell death, we preincubated PK-KO and WT glial cultures, maintained in DMEM-FCS, with BSO at 40 M, an inhibitor of the GSH synthesis, and with 3AT at 10 mM, a catalase inhibitor. BSO reduced the normally high content of GSH of both PK-KO and WT cultures Solano et al., 2006) . Treatment with 3AT for 2 h completely inhibited catalase activity (Dringen and Hamprecht, 1997) . Preincubation of glial cultures for 24 h with BSO followed by 3 h of incubation with 100 M H 2 O 2 increased the cell death observed with H 2 O 2 alone in PK-KO and WT (Fig. 4 D) . Similar findings were observed in the treatment with 3AT. The combination of treatments, BSO plus 3AT, produced similar but not additive effects. The inhibition of GSH synthesis by BSO or that of catalase by 3AT, or both, suppressed the differential susceptibility of PK-KO and WT glial cultures to H 2 O 2 at 100 M (Fig. 4 D) .
Signaling pathways involved in the H 2 O 2 -induced cell death in WT and PK-KO glial cultures
The role of ERK 1/2 and PKB in H 2 O 2 -induced cell death was investigated in WT and PK-KO glial cultures pretreated with the The cultures were preexposed to the GSH synthesis inhibitor BSO (40 M) for 24 h, the catalase activity inhibitor 3AT (10 mM) for 2 h, or a combination of both agents, then H 2 O 2 was added for 3 h at 100 M, and mitochondrial activity were measured by MTT assay. Values are the mean Ϯ SEM of three independent cultures with six replicates each. Statistical analysis was performed by two-way ANOVA (the interaction between genotype and treatment was p Ͻ 0.05), followed by Bonferroni's post hoc test.
ϩ p Ͻ 0.05; ϩϩ p Ͻ 0.01, PK-KO versus WT cultures. *p Ͻ 0.05; **p Ͻ 0.01; ***p Ͻ 0.001, H 2 O 2 -treated cultures versus controls.
⌬⌬⌬ p Ͻ 0.001 versus the corresponding H 2 O 2 treatment without inhibitors.
␦␦␦ p Ͻ 0.001 BSO plus 3AT treatment versus BSO or 3AT treatment alone. specific inhibitor of ERK upstream kinase MAP kinase kinase 1/2, PD98059 at 15 M (Dudley et al., 1995; Favata et al., 1998; Canals et al., 2003a; de Bernardo et al., 2004) and with the PI-3K inhibitor LY-294002 at 25 M (de Bernardo et al., 2004) . Both inhibitors of the signaling pathways were given 30 min before the treatment with H 2 O 2 at 200 M. Both PD98059 and LY-294002 significantly reduced, but did not completely prevent, the cell death triggered by H 2 O 2 (Fig. 5A) . The protective effects of the kinase inhibitors were greater in WT than in PK-KO glial cultures.
We also tested the specific p38 MAPK inhibitor SB203580 [4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1 H-imidazole] at 20 M and the broad-spectrum caspase inhibitor Boc-D-FMK at 30 M, but the two inhibitors did not have a significant effect on the loss of cell viability induced by H 2 O 2 at 200 M in neither WT nor PK-KO glial cultures (data not shown).
We studied the temporal profile of activation of ERK 1/2 proteins at 5, 10, 20, 30, 60, and 90 min after stressing the glial cultures with 200 M H 2 O 2 . Western blot analysis of p-ERK revealed that PK-KO glial cells had a higher increase of p-ERK after 10 min and more persistent activation than WT cultures (Fig. 5B) .
Furthermore, we investigated the role of iron in H 2 O 2 toxicity in WT and PK-KO glial cultures. For this purpose, we used two paradigms: the addition of FeSO 4 at 50 M to increase the intracellular iron stores and the membrane-permeable iron chelator DFO to reduce the iron that can be catalyst in the hydroxyl radical formation by the Fenton reaction. Cotreatment of WT and PK-KO glial cultures with FeSO 4 potentiate H 2 O 2 effect in both types of cultures, as shown by the MTT assay (Fig. 5C ), but PK-KO glia was more resistant to this insult than WT cells. DFO, at 2 or 4 mM, 2 h before the treatment with H 2 O 2 substantially reduced but did not completely prevent the toxic effects of H 2 O 2 at 200 M (Fig. 5D ). The protection provided by DFO was slightly greater in WT than PK-KO glial cultures.
Cell types affected by H 2 O 2 -induced cell death in WT and PK-KO glial cultures
We investigated whether H 2 O 2 at 100 M modifies the number of cells and the cellular phenotype in PK-KO and WT glial cultures. H 2 O 2 at 100 M for 3 h induces cell death by necrosis (Fig. 6 A, E,F ) and apoptosis (Fig. 6 B-D) . PK-KO glial cells are more resistant than WT to both mechanisms of cell death. Our study shows that the total number of cells (Fig. 7 A, B) was reduced in WT. However, the astroglial immunoreactivity (Fig. 7C,D) , expressed as integrated optical intensity of GFAP ϩ cells, and the percentage of microglial cells (Fig. 7 E, F ) was significantly increased in H 2 O 2 -treated WT cultures. These changes did not take place in PK-KO glial cultures treated with H 2 O 2 at 100 M.
Effects of aging in WT and PK-KO glial cultures
Midbrain glial cultures of WT and PK-KO mice were maintained in growth medium (DMEM-FCS) for different periods of time, from 15 d to 9 months, in culture. The effects of aging in these cultures was analyzed according to the index of proliferation, expression of proteins, GSH levels, and resistance to oxidative stress assays, performed in young cultures (1-3 months in vitro) and in aged WT and PK-KO cultures (6 -9 months in vitro).
GFAP protein levels were higher in WT than in PK-KO and in young than in old cultures (Fig. 8 A) . With respect to microglia, we found the opposite: the number of microglial cells was increased with aging and it was greater in PK-KO than in WT cultures (Fig. 8 B) . BrdU incorporation was greater in young than in old cultures. In young cultures, it was higher in WT, whereas in the old ones, it was greater in PK-KO cultures (Fig. 8C) .
Intracellular GSH was stable during aging in WT cultures. Young PK-KO cultures had a greater level of GSH than WT cultures of the same age, but this difference was inverted in old cultures (Fig. 8 D) .
We have shown recently that the expression of the heat shock protein HSP-70 changes in the striatum and midbrain of aged parkin knock-out mice (Rodriguez-Navarro et al., 2007) . Here we show that the expression of HSP-70 increases in aged cultures from both WT and PK-KO mice but much more in the first than in the second (Fig. 8 E, F ) . We also studied how age affects the vulnerability of WT and PK-KO glial cultures to the H 2 O 2 treatment. As shown in Figure  9 , A and B, old PK-KO glial cells were more sensitive than WT of a similar age to H 2 O 2 -induced loss of viability at a dose that the young PK-KO glial culture did not show any vulnerability (H 2 O 2 , 50 M). Aged PK-KO glial cultures had a greater reduction of GSH content in response to a small dose of H 2 O 2 at 50 M (Fig.  9C ) than did younger PK-KO cultures to 200 M H 2 O 2 .
Effects of WT and PK-KO glia-conditioned medium on fetal midbrain neuronal-enriched cultures
We have shown previously that GCM from mesencephalic rat astrocytes is neuroprotective for neuronal-enriched mesencephalic cultures (Mena et al., 1997a (Mena et al., , 1998b (Mena et al., , 1999 (Mena et al., , 2002 Canals et al., 2001a; Rodriguez-Martin et al., 2001) . In this study, we investigated the differential effects of PK-KO-and WT-GCM on WT midbrain neuronal cultures. The treatment of these cultures with GCM from WT or PK-KO for 24 h greatly increased the number of TH ϩ cells (Fig. 10 A, B) and [ 3 H]DA uptake (Fig. 10C ), but it did not change the total number of nuclei (data not shown). The neurotrophic effect observed with GCM from WT astrocytes was significantly greater than that of PK-KO. Similarly, WT-GCM was more effective than PK-KO-GCM in the rescue from the neuronal apoptosis induced by the incubation of the neuronal cultures with the EF12 serumfree defined medium (Fig. 10 D, E) . The percentage of microglial cells present in the WT neuronal-enriched midbrain culture was greatly diminished by the incubation in the GCM, but again, the WT GCM was more effective than the PK-KO one (Fig.  10 F) . We know that PK-KO glia cultured in stressful conditions, such as EF12, has lower intracellular GSH levels than WT cultures (Fig. 3A) and that the neurotrophic and neuroprotective effects of GCM on DA neurons are dose dependent of the GSH levels (Mena et al., 1997a) . However, GSH is not the only neuroprotective GCM compound (Mena et al., 2002) . We also tested the neuroprotective effects of WT-and PK-KO-GCM obtained in a second conditioning of the glial cultures, but in this case neither WT-nor PK-KO-GCM had any neuroprotective effect on the WT midbrain neuronal cultures.
GCM from PK-KO has lower concentration of GSH than WT-GCM (Fig. 11 A) . For that reason, we studied the dosedependent GSH effects on midbrain neuronal cultures (Fig. 11 B) and the effect of GSH supplementation to the PK-KO GCM on WT neuronal midbrain cultures (Fig.  11C ). The treatment with GSH has a dosedependent effect on the [ 3 H]DA uptake levels, and the addition of GSH to GCM from PK-KO abolished the differences between WT and PK-KO glia conditioned mediums on [ 3 H]DA uptake (Fig. 11 B, C) . We investigated changes in highaffinity DA uptake between WT and PK-KO astrocytes, because some studies suggest that astrocytic uptake is also important in regulating extracellular dopamine levels (Karakaya et al., 2007) . Both WT and PK-KO midbrain astrocytes had, however, very low levels of high-affinity [ 3 H]DA uptake, similar to blanks with the DA transporter inhibitor. WT and PK-KO mice midbrain astrocytes lack high-affinity [ 3 H]DA uptake (at 19 and 38 nM DA concentration, 37°C incubation for 20 min, and for blank blocked by DA transporter inhibitor at nanomolar concentration, even at 10 and 15 M). In rat cortical astroglia, DA transport is mediated by norepinephrine transport (Inazu et al., 1999; Takeda et al., 2002) . However, astrocytes play a role in the clearance of DA from the extracellular space, when DA is at micromolar concentration (Karakaya et al., 2007) , and, of course, astrocytes play a very important role in the DA metabolism by monoamine oxidase B (MAO-B) . It is important to notice that of dopamine neurons by impairing the ubiquitin-proteasome processing (Bharath et al., 2002; Jha et al., 2002) . PK-KO mice have mitochondrial deficits (Palacino et al., 2004) and are more sensitive than WT to the complex I inhibitor rotenone .
The role of GSH in PK-KO glia is further supported by our experiments with iron and H 2 O 2 in the presence or absence of deferoxamine. Iron accumulation in patients with PD might also contribute to oxidative stress (Bharath et al., 2002) . Iron staining is more intense in AR-PD than in controls and sporadic PD (Takanashi et al., 2001) . We found that PK-KO glial cultures are more resistant to H 2 O 2 and Fe 2ϩ plus H 2 O 2 than wild type and that this resistance is independent of deferoxamine. This suggests that young PK-KO glia has more potent antioxidants, such as GSH. We also found that the p-ERK response to H 2 O 2 was more pronounced and more persistent in PK-KO than in WT glia. This is an unexpected but consistent finding because other studies in whole mouse PK-KO brain have shown that EGF signaling via the PI3K-Akt pathway is reduced (Fallon et al., 2006) . Another animal model of PD, such as suppression of DJ-1 in Drosophila, leads to impairment of PI3K-Akt (Yang et al., 2005) .
Structural deterioration of microglia might contribute to agerelated neurodegeneration (Streit, 2006) . We found that microglia enhances the dopamine cell death in PK-KO mice ).We here demonstrate that, in aged PK-KO glial cultures, there is increased proliferation and a greater number of microglial cells than in WT, which enhances the release of proinflammatory cytokines (Teismann and Schulz, 2004; . Microglia-mediated inflammation increases the toxicity of complex I inhibitors (Hirsch and Hunot, 2000; Beal, 2003; Zoccarato et al., 2005) and the abnormality of mitochondrial function that takes place in deprivation of GSH, closing the vicious circle, which leads to cell death.
Glia is more sensitive to cell death when the levels of parkin are reduced (MacCormac et al., 2004) . We found a shift of antiapoptotic/proapoptotic proteins toward apoptosis and a reduced expression of HSP-70. The expression of HSPs in rat brain increases during aging (Calabrese et al., 2004) . The pattern of HSP-70 changes in dopamine neurons in parkinsonian midbrains (Andringa et al., 2006) , suggesting a role for this chaperone in this disease (Xu and Giffard, 1997) . Parkin interacts with HSP-70 and channel-interacting protein, two proteins that play a role in neurodegeneration (Zhang et al., 2000; Imai et al., 2002; Kalia et al., 2004; Petrucelli et al., 2004; Menendez et al., 2006) .
The key role of GSH in PK-KO glia was underlined after incubation of glia in DM for 24 h. That increased the levels of intracellular GSH, more in WT than in PK-KO glia, despite the fact that the levels of GSH in glia cultured in growth medium were greater in PK-KO cells, suggesting that PK-KO glia is unable to respond to stressful conditions. In addition, switching to DM increases H 2 O 2 levels and cell death more in PK-KO than in WT glia.
WT-GCM has more potent neurotrophic effects than PK-KO-GCM on neuronal-enriched WT mesencephalic cultures. Astrocytes secrete neurotrophic factors (Muller et al., 1995; Engele et al., 1996; Kinor et al., 2001 ). We described previously that GCM from rat mesencephalic astrocytes greatly increases the number of TH ϩ cells, TH mRNA, TH protein expression, TH neurite arborization, [
3 H]DA uptake, as well as intracellular DA levels. GCM protects DA neurons from apoptosis, MPP ϩ -induced cell death (Mena et al., 1999) , and nitric oxide (Canals et al., 2001b) . In addition, GCM greatly increases astrocytic GFAP ϩ processes. GCM is rich in antioxidants, such as GSH and ascorbic acid, and neurotrophic factors, such as glial-derived neurotrophic factor, brain-derived neurotrophic factor, nerve growth factor, and basic fibroblast growth factor, as well as novel neurotrophic proteins (Mena et al., 1998b (Mena et al., , 2002 . Ventral mesencephalic type 1 astrocytes secrete a soluble factor required for the induction of TH ϩ neurons from Nurr1 neural stem cells (Wagner et al., 1999; Arenas, 2002) . Astroglia induces neurogenesis from adult neuronal stem cells (Song et al., 2002) and guides the dopaminergic neuritic growth in vitro (Johansson and Stromberg, 2002) and in vivo (Moon et al., 2002) . We have shown that GCM induces de novo synthesis of TH and increases DA cell survival (Mena et al., 2002; de Bernardo et al., 2003 de Bernardo et al., , 2004 . Astrocytes are a key part of PD and other neurodegenerative disorders (Di Giorgio et al., 2007; Nagai et al., 2007) .
In conclusion, the combined effect of the parkin suppression and aging of glial cells may determine the death of the dopamine neurons. Intermediate mechanisms of this process include a reduction of astrocytes, proliferation of microglia, decompensation of free radical scavenging, a shift of the expression of proteins of survival and death, changes in neuroprotective chaperones, and loss of neurotrophic properties of glia from PK-KO mice. We hope that our findings help to create new tools for neuroprotective drugs for patients with PD. Characterization of WT and PK-KO glia-conditioned mediums. A, GSH concentration in GCM from WT or PK-KO. B, Dose-dependent GSH effects on WT midbrain neuronal cultures. C, [
3 H]DA uptake in WT midbrain neurons treated with PK-KO-GCM and GSH. Values are the mean Ϯ SEM of two independent cultures with six replicates each. Statistical analysis was performed by one-way ANOVA, followed by Newman-Keuls multiple comparison test. ϩ p Ͻ 0.05; ϩϩ p Ͻ 0.01; ϩϩϩ p Ͻ 0.001, PK-KO-GCM versus WT glia-conditioned medium. *p Ͻ 0.05; **p Ͻ 0.01; ***p Ͻ 0.001, GCM versus EF12 incubated cultures.
⌬ p Ͻ 0.05 PK-KO-GCM plus GSH versus PK-KO-GCM.
